Developing a next-generation Hyperplexed PCR technology
Aplex Bio has raised $896K in total funding. The most recent round was Seed. The last funding was announced in December 2021.
Aplex Bio is headquartered in Solna, Sweden.
Developing a next-generation Hyperplexed PCR technology
Aplex Bio is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Aplex Bio — Funding & Investors." VCBacked, December 31, 2021, https://www.vcbacked.co/company/aplex-bio. Accessed August 14, 2026.
VCBacked. (2021). Aplex Bio — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/aplex-bio
{{cite web |title=Aplex Bio — Funding & Investors |url=https://www.vcbacked.co/company/aplex-bio |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated